Kidney

Nephrology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
1 program
1
5-Flourouracil, Interferon-a, IL-2 and ThalidomidePhase 1/21 trial
Active Trials
NCT00277017Completed15Est. Aug 2005

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alliance Pharmaceuticals5-Flourouracil, Interferon-a, IL-2 and Thalidomide

Clinical Trials (1)

Total enrollment: 15 patients across 1 trials

NCT00277017Alliance Pharmaceuticals5-Flourouracil, Interferon-a, IL-2 and Thalidomide

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

Start: Sep 2000Est. completion: Aug 200515 patients
Phase 1/2Completed

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space